FW: Interesting New Systematic Review on Copper Surfaces

[Cath Murphy]

Members involved in refurbishments or new builds may be interested in this recently published systematic review. Researchers’ bottom line is bolded.

Chyderiotis, S., et al. (2018). “New insights on antimicrobial efficacy of copper surfaces in the healthcare environment: a systematic review.” Clinical Microbiology and Infection 24(11): 1130-1138.

Objectives Hospital-acquired infections (HAIs) are a major public health issue. The potential of antimicrobial copper surfaces in reducing HAIs’ rates is of interest but remains unclear. We conducted a systematic review of studies assessing the activity of copper surfaces (colony-forming unit (CFU)/surface, both in vitro and in situ) as well as clinical studies. In vitro study protocols were analysed through a tailored checklist developed specifically for this review, in situ studies and non-randomized clinical studies were assessed using the ORION (Outbreak Reports and Intervention studies Of Nosocomial infection) checklist and randomized clinical studies using the CONSORT guidelines. Methods The search was conducted using PubMed database with the keywords ‘copper’ and ‘surfaces’ and ‘healthcare associated infections’ or ‘antimicrobial’. References from relevant articles, including reviews, were assessed and added when appropriate. Articles were added until 30 August 2016. Overall, 20 articles were selected for review including 10 in vitro, eight in situ and two clinical studies. Results Copper surfaces were found to have variable antimicrobial activity both in vitro and in situ, although the heterogeneity in the designs and the reporting of the results prevented conclusions from being drawn regarding their spectrum and activity/time compared to controls. Copper effect on HAIs incidence remains unclear because of the limited published data and the lack of robust designs. Most studies have potential conflicts of interest with copper industries. Conclusions Copper surfaces have demonstrated an antimicrobial activity but the implications of this activity in healthcare settings are still unclear. No clear effect on healthcare associated infections has been demonstrated yet.

Cheers

Cathryn Murphy RN B. Photog MPH FSHEA FAPIC CIPC-E PhD CIC

Chief Executive Officer & Creative Director

Infection Control Plus Pty Ltd

Adjunct Assoc. Professor – Faculty of Health Services & Medicine

Bond University

QLD, Australia

E: Cath@infectioncontrolplus.com.au

M: +61 428 154154

W:http://www.infectioncontrolplus.com.au

MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

To send a message to the list administrator send an email to admin@acipc.org.au

You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

[Author]

Posts